Physician profile
Amy M Murphy
NPI 1538234950
$778.97
in general payments reported to CMS, 2019-2025
10 companies · $359 in 2025
The $359 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $123 · 2022: $90.46 · 2023: $39.90 · 2024: $167 · 2025: $359.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $566.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $565.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $213.78 | 2024-2025 | Gemtesa, Myfembree |
| Biogen, INC. | $163.80 | 2025 | Zurzuvae |
| Abbvie INC. | $127.73 | 2021-2025 | |
| Astrazeneca Pharmaceuticals Lp | $90.46 | 2022 | |
| Astellas Pharma US INC | $88.95 | 2023-2025 | Veozah, Myrbetriq |
| Coloplast Corp | $24.76 | 2025 | |
| Organon LLC | $18.48 | 2024 | |
| Exact Sciences Corporation | $18.16 | 2025 | Cologuard Collection Kit |
| Janssen Pharmaceuticals, INC | $17.81 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $15.04 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Murphy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.